Genomic Risk in Retroperitoneal Sarcoma
What You Need to Know Before You Apply
What is the purpose of this trial?
The protocol intends to explore the biology which may underlie recurrences of retroperitoneal liposarcoma. Surgery remains the only curative intent intervention for this disease. Often, tumors recur in locations within the retroperitoneum remote from the original primary tumor. This study hypothesizes that normal appearing retroperitoneal fat actually harbors underlying genetic changes which predispose to development of future liposarcoma. To accomplish this goal, retroperitoneal fat is sampled from quadrants within and remote from the primary tumor and is subsequently subjected to genetic analyses looking for such predisposing factors.
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgical Resection
Participants undergo surgical resection of their retroperitoneal liposarcoma tumor
Genetic Analysis
Retroperitoneal fat is sampled and subjected to genetic analyses to identify predisposing factors for liposarcoma
Follow-up
Participants are monitored for recurrence and genetic changes in retroperitoneal fat
What Are the Treatments Tested in This Trial?
Find a Clinic Near You
Who Is Running the Clinical Trial?
Fox Chase Cancer Center
Lead Sponsor